Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes

Older nursing home (NH) residents with glycemic overtreatment are at significant risk of hypoglycemia and other harms and may benefit from deintensification. However, little is known about deintensification practices in this setting. We conducted a cohort study from January 1, 2013 to December 31, 2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Geriatrics Society (JAGS) 2022-07, Vol.70 (7), p.2019-2028
Hauptverfasser:	Lederle, Lauren I, Steinman, Michael A, Jing, Bocheng, Nguyen, Brian, Lee, Sei J
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose Cognitive ability Cohort Studies Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - drug therapy Glycated Hemoglobin - analysis Humans Hyperglycemia Hypoglycemia Hypoglycemia - chemically induced Hypoglycemia - drug therapy Hypoglycemic Agents - therapeutic use Insulin Insulins - therapeutic use Metformin Nursing Homes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Older nursing home (NH) residents with glycemic overtreatment are at significant risk of hypoglycemia and other harms and may benefit from deintensification. However, little is known about deintensification practices in this setting. We conducted a cohort study from January 1, 2013 to December 31, 2019 among Veterans Affairs (VA) NH residents. Participants were VA NH residents age ≥65 with type 2 diabetes with a NH length of stay (LOS) ≥ 30 days and an HbA1c result during their NH stay. We defined overtreatment as HbA1c
ISSN:	0002-8614 1532-5415
DOI:	10.1111/jgs.17735